Loyola University — Chicago, Illinois

Loyola University is a clinical research site located in Chicago, Illinois, United States 60660.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Loyola University has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Invasive Fungal Infection, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation.

Sponsors: Astellas Pharma Global Development, Inc., Abbott Medical Devices, DePuy Orthopaedics.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Loyola University?

Loyola University has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Loyola University conducted?

Loyola University has 10 clinical trials on record, with 3 currently active. Their work covers Invasive Fungal Infection, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation.

Is Loyola University accredited by Crixeo Health?

Yes — Loyola University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Loyola University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.